Frank Campbell Jr., 61, says Lilly's labels didn't warn enough about stomach paralysis. Lilly says its FDA-approved labels already flag severe GI reactions.
Recap by typeshit. Full story at Inside INdiana Business.
Bloomberg says the boom in GLP-1 use has opened a risky trade in weight loss drugs brought into Brazil illegally.
The pharmacy boards group, per InsideHealthPolicy, ties reported deaths linked to retatrutide to weak enforcement against gray-market peptide sellers.
Judge Raphael Leite Guedes in Maranhão found tirzepatide counts as a home-use drug under Law 9,656/98, even when a clinic gives the shots.
Inc. reports that some Georgia clinics are still marketing an unapproved Lilly weight loss drug even as the company moves against its sale.
The filing could come as early as next week and would cover Wegovy as an obesity treatment, which could widen access in Korea.
Crypto payments to Chinese vendors selling both peptides and fentanyl ingredients rose 32% to $37.3M in 2025, TRM says, with US buyers the largest identifiable source.
Loading…